Cargando…

Cutaneous Chronic Graft-Versus-Host Disease Does Not Have the Abnormal Endothelial Phenotype or Vascular Rarefaction Characteristic of Systemic Sclerosis

BACKGROUND: The clinical and histologic appearance of fibrosis in cutaneous lesions in chronic graft-versus -host disease (c-GVHD) resembles the appearance of fibrosis in scleroderma (SSc). Recent studies identified distinctive structural changes in the superficial dermal microvasculature and matrix...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleming, Jo Nadine, Shulman, Howard M., Nash, Richard A., Johnson, Pamela Y., Wight, Thomas N., Gown, Allen, Schwartz, Stephen M.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705674/
https://www.ncbi.nlm.nih.gov/pubmed/19587802
http://dx.doi.org/10.1371/journal.pone.0006203
_version_ 1782169015656906752
author Fleming, Jo Nadine
Shulman, Howard M.
Nash, Richard A.
Johnson, Pamela Y.
Wight, Thomas N.
Gown, Allen
Schwartz, Stephen M.
author_facet Fleming, Jo Nadine
Shulman, Howard M.
Nash, Richard A.
Johnson, Pamela Y.
Wight, Thomas N.
Gown, Allen
Schwartz, Stephen M.
author_sort Fleming, Jo Nadine
collection PubMed
description BACKGROUND: The clinical and histologic appearance of fibrosis in cutaneous lesions in chronic graft-versus -host disease (c-GVHD) resembles the appearance of fibrosis in scleroderma (SSc). Recent studies identified distinctive structural changes in the superficial dermal microvasculature and matrix of SSc skin. We compared the dermal microvasculature in human c-GVHD to SSc to determine if c-GVHD is a suitable model for SSc. METHODOLOGY/PRINCIPAL FINDINGS: We analyzed skin biopsies of normal controls (n = 24), patients with SSc (n = 30) and c-GVHD with dermal fibrosis (n = 133)). Immunostaining was employed to identify vessels, vascular smooth muscle, dermal matrix, and cell proliferation. C-GVHD and SSc had similar dermal matrix composition and vascular smooth muscle pathology, including intimal hyperplasia. SSc, however, differed significantly from c-GVHD in three ways. First, there were significantly fewer (p = 0.00001) average vessels in SSc biopsies (9.8) when compared with c-GVHD (16.5). Second, in SSc, endothelial markers were decreased significantly (19/19 and 12/14 for VE cadherin and vWF (p = <0.0001 and <0.05), respectively). In contrast, 0/13 c-GVHD biopsies showed loss of staining with canonical endothelial markers. Third, c-GVHD contained areas of microvascular endothelial proliferation not present in the SSc biopsies. CONCLUSIONS/SIGNIFICANCE: The sclerosis associated with c-GVHD appears to resemble wound healing. Focal capillary proliferation occurs in early c-GVHD. In contrast, loss of canonical endothelial markers and dermal capillaries is seen in SSc, but not in c-GVHD. The loss of VE cadherin in SSc, in particular, may be related to microvascular rarefaction because VE cadherin is necessary for angiogenesis. C-GVHD is a suitable model for studying dermal fibrosis but may not be applicable for studying the microvascular alterations characteristic of SSc.
format Text
id pubmed-2705674
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-27056742009-07-09 Cutaneous Chronic Graft-Versus-Host Disease Does Not Have the Abnormal Endothelial Phenotype or Vascular Rarefaction Characteristic of Systemic Sclerosis Fleming, Jo Nadine Shulman, Howard M. Nash, Richard A. Johnson, Pamela Y. Wight, Thomas N. Gown, Allen Schwartz, Stephen M. PLoS One Research Article BACKGROUND: The clinical and histologic appearance of fibrosis in cutaneous lesions in chronic graft-versus -host disease (c-GVHD) resembles the appearance of fibrosis in scleroderma (SSc). Recent studies identified distinctive structural changes in the superficial dermal microvasculature and matrix of SSc skin. We compared the dermal microvasculature in human c-GVHD to SSc to determine if c-GVHD is a suitable model for SSc. METHODOLOGY/PRINCIPAL FINDINGS: We analyzed skin biopsies of normal controls (n = 24), patients with SSc (n = 30) and c-GVHD with dermal fibrosis (n = 133)). Immunostaining was employed to identify vessels, vascular smooth muscle, dermal matrix, and cell proliferation. C-GVHD and SSc had similar dermal matrix composition and vascular smooth muscle pathology, including intimal hyperplasia. SSc, however, differed significantly from c-GVHD in three ways. First, there were significantly fewer (p = 0.00001) average vessels in SSc biopsies (9.8) when compared with c-GVHD (16.5). Second, in SSc, endothelial markers were decreased significantly (19/19 and 12/14 for VE cadherin and vWF (p = <0.0001 and <0.05), respectively). In contrast, 0/13 c-GVHD biopsies showed loss of staining with canonical endothelial markers. Third, c-GVHD contained areas of microvascular endothelial proliferation not present in the SSc biopsies. CONCLUSIONS/SIGNIFICANCE: The sclerosis associated with c-GVHD appears to resemble wound healing. Focal capillary proliferation occurs in early c-GVHD. In contrast, loss of canonical endothelial markers and dermal capillaries is seen in SSc, but not in c-GVHD. The loss of VE cadherin in SSc, in particular, may be related to microvascular rarefaction because VE cadherin is necessary for angiogenesis. C-GVHD is a suitable model for studying dermal fibrosis but may not be applicable for studying the microvascular alterations characteristic of SSc. Public Library of Science 2009-07-09 /pmc/articles/PMC2705674/ /pubmed/19587802 http://dx.doi.org/10.1371/journal.pone.0006203 Text en Fleming et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Fleming, Jo Nadine
Shulman, Howard M.
Nash, Richard A.
Johnson, Pamela Y.
Wight, Thomas N.
Gown, Allen
Schwartz, Stephen M.
Cutaneous Chronic Graft-Versus-Host Disease Does Not Have the Abnormal Endothelial Phenotype or Vascular Rarefaction Characteristic of Systemic Sclerosis
title Cutaneous Chronic Graft-Versus-Host Disease Does Not Have the Abnormal Endothelial Phenotype or Vascular Rarefaction Characteristic of Systemic Sclerosis
title_full Cutaneous Chronic Graft-Versus-Host Disease Does Not Have the Abnormal Endothelial Phenotype or Vascular Rarefaction Characteristic of Systemic Sclerosis
title_fullStr Cutaneous Chronic Graft-Versus-Host Disease Does Not Have the Abnormal Endothelial Phenotype or Vascular Rarefaction Characteristic of Systemic Sclerosis
title_full_unstemmed Cutaneous Chronic Graft-Versus-Host Disease Does Not Have the Abnormal Endothelial Phenotype or Vascular Rarefaction Characteristic of Systemic Sclerosis
title_short Cutaneous Chronic Graft-Versus-Host Disease Does Not Have the Abnormal Endothelial Phenotype or Vascular Rarefaction Characteristic of Systemic Sclerosis
title_sort cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705674/
https://www.ncbi.nlm.nih.gov/pubmed/19587802
http://dx.doi.org/10.1371/journal.pone.0006203
work_keys_str_mv AT flemingjonadine cutaneouschronicgraftversushostdiseasedoesnothavetheabnormalendothelialphenotypeorvascularrarefactioncharacteristicofsystemicsclerosis
AT shulmanhowardm cutaneouschronicgraftversushostdiseasedoesnothavetheabnormalendothelialphenotypeorvascularrarefactioncharacteristicofsystemicsclerosis
AT nashricharda cutaneouschronicgraftversushostdiseasedoesnothavetheabnormalendothelialphenotypeorvascularrarefactioncharacteristicofsystemicsclerosis
AT johnsonpamelay cutaneouschronicgraftversushostdiseasedoesnothavetheabnormalendothelialphenotypeorvascularrarefactioncharacteristicofsystemicsclerosis
AT wightthomasn cutaneouschronicgraftversushostdiseasedoesnothavetheabnormalendothelialphenotypeorvascularrarefactioncharacteristicofsystemicsclerosis
AT gownallen cutaneouschronicgraftversushostdiseasedoesnothavetheabnormalendothelialphenotypeorvascularrarefactioncharacteristicofsystemicsclerosis
AT schwartzstephenm cutaneouschronicgraftversushostdiseasedoesnothavetheabnormalendothelialphenotypeorvascularrarefactioncharacteristicofsystemicsclerosis